Focus:
Deals League Tables
-
26 April 2019
Pharma industry deals in March 2019 total $9.75bn globally
Total pharma industry deals for March 2019 worth $9.75bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the...
-
26 April 2019
Pharma industry venture financing deals in March 2019 total $1.17bn globally
Total pharma industry venture financing deals in March 2019 worth $1.17bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and...
-
25 April 2019
Europe’s pharma industry sees a drop of 11.1% in deal activity in March 2019
Europe's pharma industry saw a drop of 11.1% in deal activity during March 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart Embed...
-
25 April 2019
Pharma industry M&A deals in March 2019 total $7.44bn globally
Total pharma industry M&A deals in March 2019 worth $7.44bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...
-
24 April 2019
US pharma industry sees a drop of 1.3% in deal activity in March 2019
The US pharma industry saw a drop of 1.3% in overall deal activity during March 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
-
24 April 2019
North America’s pharma industry sees a drop of 4.8% in deal activity in March 2019
North America's pharma industry saw a drop of 4.8% in deal activity during March 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...
-
26 March 2019
Europe’s pharma industry sees a drop of 27.3% in deal activity in Q4 2018
Europe's pharma industry saw a drop of 27.3% in overall deal activity during Q4 2018, when compared to the last four-quarter average, according to GlobalData's deals database. Embed this chart...
-
26 March 2019
North America’s pharma industry sees a rise of 1% in deal activity in Q4 2018
North America's pharma industry saw a rise of 1% in overall deal activity during Q4 2018, when compared to the last four-quarter average, according to GlobalData's deals database. Embed this...
-
26 March 2019
Europe’s pharma industry sees a drop of 3.9% in deal activity in February 2019
Europe's pharma industry saw a drop of 3.9% in deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart Embed...
-
26 March 2019
North America’s pharma industry sees a drop of 15.7% in deal activity in February 2019
North America's pharma industry saw a drop of 15.7% in deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...